Beta-Cell Function and Glycemic Control Following One-Year Vildagliptin Treatment, and after 12-Week Washout, in Drug-Naive Patients with Type 2 Diabetes and Mild Hyperglycemia

被引：0
|
作者：
Bunck, Mathijs C.
Poelma, Marieke
Goede, Diane L.
Van Golen, Larissa W.
Van Genugten, Renate E.
Eekhoff, E. Marelise
Schweizer, Anja
Heine, Robert J.
Foley, James E.
Nijpels, Giel
Diamant, Michaela
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A17 / A17
页数：1
相关论文
共 40 条
  • [31] Glycaemia, Beta-Cell Function, and Incretin Hormones Post-OGTT One Year after Gastric Bypass and Sleeve Gastrectomy in Patients with Morbid Obesity and Type 2 Diabetes: An RCT (Oseberg Study)
    Fatima, Farhat
    Hjelmesaeth, Joran
    Birkeland, Kare I.
    Gulseth, Hanne L.
    Hertel, Jens K.
    Svanevik, Marius
    Sandbu, Rune
    Hartmann, Bolette
    Holst, Jens J.
    Hofso, Dag
    DIABETES, 2020, 69
  • [32] Comparison of Glycemic Control and Beta-Cell Function in Newly Diagnosed Type 2 Diabetes Patients Treated with Exenatide, Insulin or Pioglitazone: A Multicentre, Randomized, Parallel-Group Trial (CONFIDENCE)
    Xu, Wen
    Bi, Yan
    Sun, Zilin
    Li, Jin
    Guo, Lixin
    Yang, Tao
    Wu, Ge
    Shi, Lixin
    Feng, Zhengping
    Qiu, Lin
    Li, Qiang
    Guo, Xiaohui
    Luo, Zuojie
    Lu, Juming
    Shan, Zhongyan
    Yang, Wenying
    Ji, Qiuhe
    Yan, Li
    Li, Hong
    Yu, Xuefeng
    Li, Shaoqing
    Zhou, Zhiguang
    Lv, Xiaofeng
    Liang, Zhen
    Lin, Shaoda
    Zeng, Longyi
    Yan, Jinhua
    Ji, Linong
    Weng, Jianping
    DIABETES, 2014, 63 : A86 - A86
  • [33] Effects of Dulaglutide and Trelagliptin on B-Cell Function after One Year in Patients with Type 2 Diabetes: DUET-Beta Extension Study
    Kondo, Yoshinobu
    Satoh, Shinobu
    Terauchi, Yasuo
    DIABETES, 2019, 68
  • [34] INSULIN REQUIREMENTS AND RESIDUAL BETA-CELL FUNCTION 12 MONTHS AFTER CONCLUDING IMMUNOTHERAPY IN TYPE-I DIABETIC-PATIENTS TREATED WITH COMBINED AZATHIOPRINE AND THYMOSTIMULIN ADMINISTRATION FOR ONE YEAR
    MONCADA, E
    SUBIRA, ML
    OLEAGA, A
    GONI, F
    SANCHEZIBARROLA, A
    MONREAL, M
    SEVILLA, M
    GONI, MJ
    YOLDI, A
    TERAN, D
    LLORENTE, I
    JOURNAL OF AUTOIMMUNITY, 1990, 3 (05) : 625 - 638
  • [35] Association of rs5219 KCNJ11 Gene Polymorphism with Pancreatic Beta-Cell Function, Insulin Resistance, and Glycemic Control of Sulfonylurea-treated Malaysian Type 2 Diabetes Patients
    Loganadan, Navin K.
    Huri, Hasniza Zaman
    Vethakkan, Shireene R.
    Hussein, Zanariah
    DIABETES, 2016, 65 : A428 - A428
  • [36] LONG-TERM CONTROL OF INSULIN-DEPENDENT TYPE 2 DIABETES AND IMPROVEMENT OF DIABETIC COMPLICATIONS IN PATIENTS WITH OVERWEIGHT AND I° OBESITY AFTER RYGB IS INDEPENDENT OF PREOPERATIVE BETA-CELL FUNCTION Type 2 diabetes and metabolic surgery
    Mueller, B.
    Billeter, A.
    Schwarz, A.
    Ruehle, A.
    Boskovic, A.
    Nawroth, P.
    OBESITY SURGERY, 2022, 32 (SUPPL 2) : 336 - 336
  • [37] (3-cell function and long-term glycemic control in patients newly diagnosed with type 2 diabetes with moderate hyperglycemia after a 6-month course of basal insulin therapy
    Kuo, Chin-Sung
    Chen, Harn-Shen
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 215
  • [38] Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211) A 12-week, double-blind, randomized, controlled trial
    Madsbad, S
    Schmitz, O
    Ranstam, J
    Jakobsen, G
    Matthews, DR
    DIABETES CARE, 2004, 27 (06) : 1335 - 1342
  • [39] Improvement of β-cell function ameliorated glycemic variability in patients with newly diagnosed type 2 diabetes after short-term continuous subcutaneous insulin infusion or in combination with sitagliptin treatment: a randomized control trial
    Yuan, Guoyue
    Hu, Hao
    Wang, Su
    Yang, Qichao
    Yu, Shuqin
    Sun, Wenjun
    Qian, Weiyun
    Mao, Caoming
    Zhou, Libin
    Chen, Dezhi
    Wang, Zhaoling
    Gong, Qin
    Wang, Dong
    ENDOCRINE JOURNAL, 2015, 62 (09) : 817 - 834
  • [40] A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-naive type 2 diabetes mellitus patients
    Borges, J. L. C.
    Bilezikian, J. P.
    Jones-Leone, A. R.
    Acusta, A. P.
    Ambery, P. D.
    Nino, A. J.
    Grosse, M.
    Fitzpatrick, L. A.
    Cobitz, A. R.
    DIABETES OBESITY & METABOLISM, 2011, 13 (11): : 1036 - 1046
1234